Baxiva Email Formats

Biotechnology Research • Stadtkreis 1 Altstadt, Zurich, Switzerland • 1-10 Employees

Key Contact at Baxiva

Giorgia Greter

Co-Founder And Ceo

Company overview

Headquarters	Stadtkreis 1 Altstadt, Zurich, Switzerland
Website	baxiva.com
NAICS	541714
Employees	1-10

About Baxiva

Baxiva is developing the first K-antigen-targeting vaccine to prevent E. coli infections, offering the highest level of protection against UTIs and systemic infections.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Entry

Manager

Employees by Department

Baxiva has 4 employees across 4 departments.

Departments

Number of employees

Funding Data

Explore Baxiva's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2025-09-21	9	$3,000,000

Funding Insights

$3,000,000

Total funding amount

$3,000,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

Baxiva is located in Stadtkreis 1 Altstadt, Zurich, CH.

Baxiva has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Baxiva has raised a total of $3,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.